kabutan

Renascience Inc., First Half Ordinary Profit Loss Narrows, July-September Ordinary Profit Loss Narrows

Thu Nov 14, 2024 3:30 pm JST Earnings

4889 Renascience Inc. 【J-GAAP】

Earnings Report

Renascience Inc. <4889> [TSE-G] announced its financial results after the market closed on November 14th (15:30). The ordinary loss (non-consolidated) for the cumulative second quarter of the fiscal year ending March 2025 (April to September) was a reduced loss of 92 million yen (compared to a loss of 94 million yen in the same period last year).

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary loss for the October to March period (second half) is expected to expand to a loss of 165 million yen (compared to a loss of 157 million yen in the same period last year).

In the most recent three-month period, from July to September (2Q), the ordinary loss improved to a deficit of loss of 56 million yen (compared to a loss of 96 million yen in the same period last year). However, the operating profit/loss margin drastically worsened from -355.6% in the same period last year to -360.0%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 20 -152 -152 -153 -12.1 ー Nov 10, 2022 J-GAAP
Apr - Sep, 2023 120 -94 -94 -95 -7.5 ー Nov 9, 2023 J-GAAP
Apr - Sep, 2024 55 -90 -92 -72 -5.7 ー Nov 14, 2024 J-GAAP
YoY -54.2% +4.3% +2.1% +24.2% +23.5%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 Guidance ー ー ー ー － 0 May 9, 2024 J-GAAP
Apr - Sep, 2024 Results 55 -90 -92 -72 -5.7 0 Nov 14, 2024 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 74 -158 -157 -163 -12.8 0 May 9, 2024 J-GAAP
Oct - Mar, 2024 Guidance 50 -167 -165 -19 -1.5 0 Nov 14, 2024 J-GAAP
YoY -32.4% -5.7% -5.1% +88.3% +88.4%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 100 -333 -333 -335 -26.4 0 May 11, 2023 J-GAAP
Mar, 2024 194 -252 -251 -258 -20.3 0 May 9, 2024 J-GAAP
Mar, 2025 Guidance 105 -257 -257 -91 -7.2 0 Jul 3, 2024 J-GAAP
YoY -45.9% -2.0% -2.4% +64.7% +64.8%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 27 -96 -96 -97 -7.7 -355.6 Nov 9, 2023 J-GAAP
Oct - Dec, 2023 0 -127 -127 -127 -10.0 -Inf Feb 8, 2024 J-GAAP
Jan - Mar, 2024 74 -31 -30 -36 -2.8 -41.9 May 9, 2024 J-GAAP
Apr - Jun, 2024 40 -36 -36 -16 -1.3 -90.0 Aug 8, 2024 J-GAAP
Jul - Sep, 2024 15 -54 -56 -56 -4.5 -360.0 Nov 14, 2024 J-GAAP
YoY -44.4% +43.8% +41.7% +42.3% +41.8%

Related Articles